PROM1 and small cell lung carcinoma: The mRNA expression levels of these CSC markers increased in the SCLC cells derived from the Cisplatin-treated mice; at least one of those markers significantly increased in the SCLC cell from each Cisplatin-treated mouse compared with H69 cells (CD47 in mouse 1; CD133 and CD87 in mouse 2; CD133 and CD47 in mouse 3) (p<0.05) (Figure 5D).